Paper Details

Paper Title

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies.

Paper Journal Title

Eur J Cancer

Paper Citation Count

103

Paper Publication Year

2012

Bio Mention

B-cell malignancies, BACKGROUND SF1126, CD20+, CD20+ B-cell malignancies, CLL, CLL cells, PATIENTS, PI3K, SF1126, advanced malignancies, advanced solid tumours, diarrhoea, human, lymphocyte, mTORC, p-AKT, patient, patients, rituximab, solid and B-cell malignancies

Mesh Descriptor

Paper Details

Column Actions

Datasets